CorMedix
Stock Forecast, Prediction & Price Target
CorMedix Financial Estimates
CorMedix Revenue Estimates
CorMedix EBITDA Estimates
CorMedix Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $190.93K N/A | $65.40K -65.74% | $0 -100% | Avg: $81.92M Low: $70.83M High: $101.46M avg. 0% | Avg: $161.96M Low: $140.03M High: $200.59M avg. 97.70% | Avg: $251.90M Low: $217.79M High: $311.98M avg. 55.52% | Avg: $329.54M Low: $284.92M High: $408.13M avg. 30.82% |
Net Income
% change YoY
| $-28.21M N/A | $-29.70M -5.28% | $-46.33M -56.01% | Avg: $-1.36M Low: $-22.90M High: $24.94M avg. 97.06% | Avg: $82.08M Low: $32.57M High: $78.39M avg. 6131.22% | Avg: $113.25M Low: $93.32M High: $148.37M avg. 37.97% | Avg: $152.19M Low: $125.41M High: $199.38M avg. 34.38% |
EBITDA
% change YoY
| $-29.44M N/A | $-30.29M -2.89% | $-48.88M -61.35% | Avg: $-49.15M Low: $-60.87M High: $-42.50M avg. -0.54% | Avg: $-97.18M Low: $-120.35M High: $-84.02M avg. -97.70% | Avg: $-151.14M Low: $-187.18M High: $-130.67M avg. -55.52% | Avg: $-197.72M Low: $-244.88M High: $-170.95M avg. -30.82% |
EPS
% change YoY
| -$0.75 N/A | -$0.74 1.33% | -$0.91 -22.97% | Avg: -$0.05 Low: -$0.45 High: $0.49 avg. 94.78% | Avg: $1.09 Low: $0.64 High: $1.54 avg. 2394.73% | Avg: $2.23 Low: $1.83 High: $2.91 avg. 104.12% | Avg: $2.99 Low: $2.46 High: $3.92 avg. 34.38% |
Operating Expenses
% change YoY
| $29.47M N/A | $30.68M 4.09% | $48.95M 59.54% | Avg: $7.95B Low: $6.87B High: $9.84B avg. 16142.50% | Avg: $15.72B Low: $13.59B High: $19.47B avg. 97.70% | Avg: $24.45B Low: $21.14B High: $30.28B avg. 55.52% | Avg: $31.98B Low: $27.65B High: $39.61B avg. 30.82% |
FAQ
What is CorMedix stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 1575.16% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -22.90M, average is -1.36M and high is 24.94M.
What is CorMedix stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 46.01% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $70.83M, average is $81.92M and high is $101.46M.
What is CorMedix stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 657.00% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.45, average is -$0.05 and high is $0.49.
What is the best performing analyst?
In the last twelve months analysts have been covering CorMedix stock. The most successful analyst is Gregory Renza.